MODY2: Clinical and molecular genetic characteristics of 13 cases of the disease. The first description of MODY in Russia
https://doi.org/10.14341/probl20095533-7
Abstract
Maturity-onset diabetes of the young (MODY) is a clinically heterogenic group of diseases, with an autosomal dominant mode of inheritance and gene mutations resulting in dysfunction of pancreatic β cells. The type of diabetes and further treatment policy can be reliably determined on the basis of the data of a molecular genetic study that confirms gene mutations. Today there are known mutations of 8 genes, of which glucokinase (GCK) gene mutation that leads to the development of MODY2 and occurs most frequently. The spread of this mutation among DM patients in our country has not been studied. The diagnosis of MODY2 was established in 13 members of 5 families with the clinical picture typical of this type. The molecular genetic study revealed 4 new and 1 earlier described mutations. The findings extend ideas on the molecular bases of MODY, which creates conditions for improving the diagnosis of this disease, genetic counseling and the development of pathogenetically founded approaches to treatment.
About the Authors
I I DedovEndocrinology Research Centre
Russian Federation
Natal'ya Anatol'evna Zubkova
Endocrinology Research Centre
Russian Federation
N Yu Arbatskaya
Moscow city clinical hospital #1 n.a. N.I.Pirogov
Russian Federation
A G Akopova
Moscow City diabetology center
Russian Federation
A N Tyul'pakov
Endocrinology Research Centre
Russian Federation
References
1. Barrio R., Bellanne-Chantelot C., Moreno J. C. et al. // J. Clin. Enocrinol. Metab. - 2002. - Vol. 87. - P. 2532-2539.
2. Ellard S., Beards F., Allen L. I. S. et al. // Diabetologia. - 2000. - Vol. 43. - P. 250-253.
3. Ellard S., Thomas K., Edghill E. L. et al. // Diabetologia. - 2007. - Vol. 50. - P. 2313-2317.
4. Fajans S. S., Bell G. I., Polonsky K. S. // N. Engl. J. Med. - 2001. - Vol. 345, N 13. - P. 971-980.
5. Feigerlova E., Pruhova S., Dittertova L. et al. // Eur. J. Pediatr. - 2006. - Vol. 165. - P. 446-452.
6. Frayling T. M., Evans J. C., Bulman M. P. et al. // Diabetes. - 2001. - Vol. 50. - Suppl. 1. - P. S94-S100.
7. Froguel P., Zouali H., Vionnet N. et al. // N. Engl. J. Med. - 1993. - Vol. 328. - P. 697-702.
8. Garcia-Herrero C. M., Galдn M., Vincent O. // Diabetologia. - 2007. - Vol. 50. - P. 325-333.
9. Gill-Carey O., Shields B., Colclough K. et al. // Diabet. Med. - 2007. - Vol. 24. - Suppl. 1. - P. 6.
10. Gloyn A. L. // Hum. Mutat. - 2003. - Vol. 22. - P. 353-362.
11. Hattersley A. T., Beards F., Ballantyne E. et al. // Nat. Genet. - 1998. - Vol. 19. - P. 268-270.
12. Jian Yu Xu, Qing Hong Dan, Vivian Chan et al. // Eur. J. Hum. Genet. - 2005. - Vol. 13. - P. 422-427.
13. Lenderman H. // Lancet. - 1995. - Vol. 345. - P. 648.
14. Massa O., Meschi F., Cuesta-Munoz A. et al. // Diabetologia. - 2001. - Vol. 44. - P. 898-905.
15. Miller S. P., Anand G. R., Karschnia E. J. et al. // Diabetes. - 1999. - Vol. 48. - P. 1645-1651.
16. Schnyder S., Mullis P., Ellard S. et al. // Swiss. Me. Wkly. - 2005. - Vol. 135. - P. 352-356.
17. Spyer G., Hasttersley A. T., Sykes J. E. et al. // Am. J. Obstet. Gynecol. - 2001. - Vol. 185. - P. 240-241.
18. Tattersall R. B. // Quart. J. Med. - 1974. - Vol. 43. - P. 339-357.
19. Tattersall R. B., Fajans S. S. // Diabetes. - 1975. - Vol. 24. - P. 44-53.
Review
For citations:
Dedov I.I., Zubkova N.A., Arbatskaya N.Yu., Akopova A.G., Tyul'pakov A.N. MODY2: Clinical and molecular genetic characteristics of 13 cases of the disease. The first description of MODY in Russia. Problems of Endocrinology. 2009;55(3):3-7. (In Russ.) https://doi.org/10.14341/probl20095533-7
Views:
22640
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
